N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2015-10-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1517862112PMID 26453556PMCID PMC4629350
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vasostatin‐1 antigenic epitope mapping for induction of cellular and humoral immune responses to chromogranin A autoantigen in NOD mice

  2014cited by this paper
• Germline TRAV5D-4 T-Cell Receptor Sequence Targets a Primary Insulin Peptide of NOD Mice

  2012cited by this paper
• Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?

  2012cited by this paper
• Diabetogenic T-Cell Clones Recognize an Altered Peptide of Chromogranin A

  2012cited by this paper
• Insulin as a key autoantigen in the development of type 1 diabetes

  2011cited by this paper
• Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse

  2011cited by this paper
• Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders.

  2011cited by this paper
• Cutting Edge: Vasostatin-1–Derived Peptide ChgA29–42 Is an Antigenic Epitope of Diabetogenic BDC2.5 T Cells in Nonobese Diabetic Mice

  2011influential reference
• Multiple antigens versus single major antigen in type 1 diabetes: arguing for multiple antigens

  2011cited by this paper
• Crystal structure of HLA-DP2 and implications for chronic beryllium disease

  2010cited by this paper
• Genetics, pathogenesis and clinical interventions in type 1 diabetes

  2010cited by this paper
• Chromogranin A is an autoantigen in type 1 diabetes

  2010cited by this paper
• Molecular targeting of islet autoantigens.

  2010cited by this paper
• Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register

  2010cited by this paper
• Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis

  2010cited by this paper
• Features and development of Coot

  2010cited by this paper
• Transpeptidation and reverse proteolysis and their consequences for immunity.

  2009cited by this paper
• The Crucial Role of Chromogranins in Storage and Exocytosis Revealed Using Chromaffin Cells from Chromogranin A Null Mouse

  2008influential reference
• On the Pathogenicity of Autoantigen-Specific T-Cell Receptors

  2008cited by this paper
• Phaser crystallographic software

  2007influential reference
• Neuropeptides of the islets of Langerhans: a peptidomics study.

  2007cited by this paper
• Native chemical ligation in covalent caspase inhibition by p35.

  2006cited by this paper
• Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.

  2005cited by this paper
• Cutting and Pasting Antigenic Peptides

  2004cited by this paper
• Cell biology. Cutting and pasting antigenic peptides.

  2004cited by this paper
• Immune recognition of a human renal cancer antigen through post-translational protein splicing

  2004cited by this paper
• Mimotopes for Alloreactive and Conventional T Cells in a Peptide–MHC Display Library

  2004cited by this paper
• An Antigenic Peptide Produced by Peptide Splicing in the Proteasome

  2004cited by this paper
• research papers Acta Crystallographica Section D Biological

  2003cited by this paper
• Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones.

  2002influential reference
• Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice1

  2001influential reference
• Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.

  2000influential reference
• A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.

  2000influential reference
• Production and characterization of T cell hybridomas.

  2000cited by this paper
• Staphylococcus aureus sortase, an enzyme that anchors surface proteins to the cell wall.

  1999cited by this paper
• Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes.

  1998cited by this paper
• Ontogenetic expression of chromogranin A and its derived peptides, WE-14 and pancreastatin, in the rat neuroendocrine system

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders.

  1996cited by this paper
• Diabetogenic T-Cell Clones

  1996cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Pancreatic islet-specific T-cell clones from nonobese diabetic mice.

  1989influential reference
• Posttranslational processing of concanavalin A precursors in jackbean cotyledons

  1986cited by this paper
• THE ENZYMATIC SYNTHESIS OF PEPTIDE BONDS

  1938cited by this paper

• Mechanisms of B Cell Tolerance in Health and Autoimmunity.

  2025cites this paper
• A complex role of chromogranin A and its peptides in inflammation, autoimmunity, and infections

  2025cites this paper
• Can autoimmune disease be cured by deep CD19+ cell depletion?

  2025cites this paper
• Autoimmunity, epitope analysis, and molecular mimicry.

  2025cites this paper
• Antigen-specific T cells and autoimmunity.

  2024cites this paper
• Non-mutational neoantigens in disease

  2024cites this paper
• Soluble antigen arrays provide increased efficacy and safety over free peptides for tolerogenic immunotherapy

  2024cites this paper
• Immunotherapy for Type 1 Diabetes: Mechanistic Insights and Impact of Delivery Systems.

  2024cites this paper
• Essential role of interferon-regulatory factor 4 in regulating diabetogenic CD4+ T and innate immune cells in autoimmune diabetes in NOD mice.

  2024cites this paper
• Antigen-specific T cell responses in autoimmune diabetes

  2024cites this paper
• Epitope-based precision immunotherapy of Type 1 diabetes

  2023cites this paper
• Enhancement of in vitro cholesterol-lowering and anti-diabetic activities of gluten hydrolysate prepared using kiwifruit protease as affected by ultrasound and atmospheric cold plasma post-treatments

  2023cites this paper
• Soluble antigen arrays improve the efficacy and safety of peptide-based tolerogenic immunotherapy

  2023influential citation
• Selected Serum Markers Associated with Pathogenesis and Clinical Course of Type 1 Diabetes in Pediatric Patients—The Effect of Disease Duration

  2023cites this paper
• Using mass spectrometry to identify neoantigens in autoimmune diseases: The type 1 diabetes example.

  2023cites this paper
• Engineered Treg cells: The heir to the throne of immunotherapy.

  2023cites this paper
• A Novel Tolerogenic Antibody Targeting Disulfide-Modified Autoantigen Effectively Prevents Type 1 Diabetes in NOD Mice

  2022cites this paper
• Calcitonin gene-related peptide is a potential autoantigen for CD4 T cells in type 1 diabetes

  2022influential citation
• Novel Insights into the Immunotherapy-Based Treatment Strategy for Autoimmune Type 1 Diabetes

  2022cites this paper
• Hidden in Plain View: Discovery of Chimeric Diabetogenic CD4 T Cell Neo-Epitopes

  2021influential citation
• Know thy immune self and non‐self: Proteomics informs on the expanse of self and non‐self, and how and where they arise

  2021cites this paper
• Role and function of granin proteins in diabetes mellitus

  2021cites this paper
• Regulatory peptides and systems biology: A new era of translational and reverse‐translational neuroendocrinology

  2020cites this paper
• Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation

  2020cites this paper
• The Challenges of Identifying Environmental Determinants of Type 1 Diabetes: In Search of the Holy Grail

  2020cites this paper
• A systematic review of chromogranin A (CgA) and its biomedical applications, unveiling its structure-related functions

  2020cites this paper
• A biomimetic five-module chimeric antigen receptor (5MCAR) designed to target and eliminate antigen-specific T cells

  2020cites this paper
• mouse diabetogenic TCR I.29

  2019cites this paper
• How C-terminal additions to insulin B-chain fragments create superagonists for T cells in mouse and human type 1 diabetes

  2019influential citation
• A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in Type 1 diabetes.

  2019cites this paper
• Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation

  2019cites this paper
• Next-generation regulatory T cell therapy

  2019cites this paper
• Catestatin as a Target for Treatment of Inflammatory Diseases

  2018cites this paper
• Breaking self‐tolerance during autoimmunity and cancer immunity: Myeloid cells and type I IFN response regulation

  2018cites this paper
• HLA variation and disease

  2018cites this paper
• Class II MHC antigen processing in immune tolerance and inflammation

  2018cites this paper
• Chromogranin-A and its derived peptides and their pharmacological effects during intestinal inflammation.

  2018cites this paper
• T1D Autoantibodies: room for improvement?

  2017cites this paper
• Increased Effector Memory Insulin-Specific CD4+ T Cells Correlate With Insulin Autoantibodies in Patients With Recent-Onset Type 1 Diabetes

  2017cites this paper
• Stacking the Deck: Studies of Patients with Multiple Autoimmune Diseases Propelled Our Understanding of Type 1 Diabetes as an Autoimmune Disease

  2017cites this paper
• C-terminal modification of the insulin B:11–23 peptide creates superagonists in mouse and human type 1 diabetes

  2017influential citation
• New insights into non-conventional epitopes as T cell targets: The missing link for breaking immune tolerance in autoimmune disease?

  2017cites this paper
• Adaptive Immunity Is the Key to the Understanding of Autoimmune and Paraneoplastic Inflammatory Central Nervous System Disorders

  2017cites this paper
• T Cell-Mediated Beta Cell Destruction: Autoimmunity and Alloimmunity in the Context of Type 1 Diabetes

  2017cites this paper
• Chromogranin A Regulation of Obesity and Peripheral Insulin Sensitivity

  2017cites this paper
• Environmental risk factors for type 1 diabetes.

  2016cites this paper
• Induction of antigen-specific tolerance and development of autoreactive T cells in an experimental model of autoimmune diabetes

  2016cites this paper
• Estudio de terapias antígeno-específicas para la prevención de la diabetes tipo 1 en el ratón nod

  2016cites this paper
• Efficient Presentation of Multiple Endogenous Epitopes to Both CD4+ and CD8+ Diabetogenic T Cells for Tolerance

  2016cites this paper
• Team science in type 1 diabetes: new insights from the Network for Pancreatic Organ Donors with Diabetes (nPOD)

  2016cites this paper